Skip to main content
    N

    NeuroSense Therapeutics Ltd. Warrant (NRSNW)

    Official site

    BIOTECHNOLOGY • NASDAQ

    $0.01
    +0.00 (+0.00%)

    Last updated: Nov 16, 2026 at 4:00 PM ET

    Earnings

    Upcoming Estimates

    Results pendingPeriod ending Jun 30, 2026
    EPS ConsensusN/A
    RangeN/A
    Revenue Consensus
    N/A
    RangeN/A
    1 analysts
    Results pendingPeriod ending Sep 30, 2026
    EPS ConsensusN/A
    RangeN/A
    Revenue Consensus
    N/A
    RangeN/A
    1 analysts
    PeriodReportedEst.RangeSurpriseB/MAnalystsRevisionsYoY
    Dec 26EST
    Date TBD
    -N/AN/A-----
    Sep 26EST
    Date TBD
    -N/AN/A-----
    Jun 26EST
    Date TBD
    -N/AN/A-----
    Mar 21
    Reported Jun 30
    -$0.27N/AN/A-----372.8%
    Dec 20
    Reported Mar 31
    -$0.27N/AN/A-----372.8%
    Sep 20
    Reported Dec 31
    -$0.20N/AN/A-----
    Jun 20
    Reported Sep 30
    -$0.20N/AN/A-----
    Mar 20
    Reported Jun 30
    -$0.06N/AN/A-----
    Dec 19
    Reported Mar 31
    -$0.06N/AN/A-----

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin0.00%Operating Margin0.00%
    ROE-2175.00%ROICN/A
    Financial Health
    Debt/Equity0.00xInterest CoverageN/A
    Current Ratio0.28xQuick Ratio0.28x
    Trading Statistics
    Beta1.72Avg Volume7.82K
    52-Week High$0.4552-Week Low$0.00

    Technical Indicators Dashboard

    As of Nov 16, 2026, the price is 78.0% below its 50-day moving average, and the 50-day average is below the 200-day average. The 14-day RSI is 36.2, in the neutral range between 30 and 70.

    Moving Averages

    SMA 10$0.01
    SMA 20$0.01
    SMA 50$0.02
    SMA 200$0.11
    EMA 10$0.01
    EMA 20$0.01
    EMA 50$0.03
    EMA 200$0.12

    MACD

    Line: -0.01Signal: -0.01Hist: 0.00

    ADX

    ADX: 14.8+DI: 34.3-DI: 41.1

    Aroon & PSAR

    Aroon Up20.0
    Aroon Down4.0
    PSAR$0.00

    Bollinger Bands

    Upper Band$0.01
    Lower Band$0.00
    %B Position10400%(Upper)
    Band Width0.26

    RSI (14-Day)

    Neutral
    36.2

    Momentum Oscillators

    Stoch %K2.7
    Stoch %D5.3
    Williams %R-97.7
    ROC (10d)-26.7%
    Momentum-0.00
    CCI (20d)-118.9
    MFI (14d)66.8

    Volatility Measures

    ATR (14d)$0.00(55.5%)
    StdDev (20d)0.00
    Hist Vol395.8%(High)

    Volume Flow

    VWAP$0.01
    OBV48.3K
    AD Line-139.1K
    CMF (20d)-0.619

    Volume Metrics

    Avg Vol (20d)7.9K
    Vol Ratio0.9x
    VWMA (20d)$0.01

    Pivot Points

    R3$0.01
    R2$0.01
    R1$0.01
    Pivot Point$0.01
    S1$0.01
    S2$0.01
    S3$0.01

    Advanced Oscillators

    TSI-29.53
    Ultimate Osc23.1
    KST-547.60

    Financial Performance

    Related GNG Research

    No research available

    Be the first to write about NRSNW

    News

    No news available

    Company news will appear here when available

    NRSNW Valuation

    NRSNW Profitability: Margins, ROIC and FCF

    NeuroSense Therapeutics Ltd. Warrant (NRSNW) has an operating margin of 0.0% and a net margin of 0.0%.

    Operating margin
    0.0%
    Net margin
    0.0%
    ROE
    -2175.0%
    NRSNW financial statements

    NeuroSense Therapeutics Ltd. Warrant Competitors

    The companies most similar to NeuroSense Therapeutics Ltd. Warrant (NRSNW) include Sionna Therapeutics, Inc. Common Stock, Neurogene and ProMIS Neurosciences.

    Sector: Healthcare

    Updated Oct 25, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.